Search Results - "Roelf Valkema"

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study by Noordman, Bo Jan, Spaander, Manon C W, Valkema, Roelf, Wijnhoven, Bas P L, van Berge Henegouwen, Mark I, Shapiro, Joël, Biermann, Katharina, van der Gaast, Ate, van Hillegersberg, Richard, Hulshof, Maarten C C M, Krishnadath, Kausilia K, Lagarde, Sjoerd M, Nieuwenhuijzen, Grard A P, Oostenbrug, Liekele E, Siersema, Peter D, Schoon, Erik J, Sosef, Meindert N, Steyerberg, Ewout W, van Lanschot, J Jan B, Doukas, Michael, Krak, Nanda C, Poley, Jan-Werner, van Rij, Caroline M, Bergman, Jaques JGHM, Gisbertz, Suzanne S, van Laarhoven, Hanneke WM, Meijer, Sybren L, Goense, Lucas, Haj Mohammad, Nadia, Hobbelink, Monique GG, Offerhaus, G Johan A, Vleggaar, Frank, Curvers, Wouter L, Creemers, Geert-Jan, Roef, Mark J, van der Sangen, Maurice JC, Buijsen, Jeroen, Riedl, Robert G, Schreurs, Wendy MJ, Warmerdam, Fabienne ARM, Janssen, MJR, van der Post, Chella, Radema, Sandra A, Rosman, Camiel, Rütten, Heidi

“…After neoadjuvant chemoradiotherapy for oesophageal cancer, roughly half of the patients with squamous cell carcinoma and a quarter of those with…”
Get full text

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial by Noordman, Bo Jan, Wijnhoven, Bas P L, Lagarde, Sjoerd M, Boonstra, Jurjen J, Coene, Peter Paul L O, Dekker, Jan Willem T, Doukas, Michael, van der Gaast, Ate, Heisterkamp, Joos, Kouwenhoven, Ewout A, Nieuwenhuijzen, Grard A P, Pierie, Jean-Pierre E N, Rosman, Camiel, van Sandick, Johanna W, van der Sangen, Maurice J C, Sosef, Meindert N, Spaander, Manon C W, Valkema, Roelf, van der Zaag, Edwin S, Steyerberg, Ewout W, van Lanschot, J Jan B

“…Neoadjuvant chemoradiotherapy (nCRT) plus surgery is a standard treatment for locally advanced oesophageal cancer. With this treatment, 29% of patients have a…”
Get full text

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study by Kersten, Marie José, Driessen, Julia, Zijlstra, Josée M, Plattel, Wouter J, Morschhauser, Franck, Lugtenburg, Pieternella J, Brice, Pauline, Hutchings, Martin, Gastinne, Thomas, Liu, Roberto, Burggraaff, Coreline N, Nijland, Marcel, Tonino, Sanne H, Arens, Anne I J, Valkema, Roelf, van Tinteren, Harm, Lopez-Yurda, Marta, Diepstra, Arjan, De Jong, Daphne, Hagenbeek, Anton

“…Achieving a metabolic complete response (mCR) before high-dose chemotherapy (HDC) and autologous peripheral blood stem-cell transplant (auto-PBSCT) predicts…”
Get full text

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors by Kwekkeboom, Dik J, Kam, Boen L, van Essen, Martijn, Teunissen, Jaap J M, van Eijck, Casper H J, Valkema, Roelf, de Jong, Marion, de Herder, Wouter W, Krenning, Eric P

“…Somatostatin receptor imaging (SRI) with [111In-DTPA0]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic neuroendocrine…”
Get full text

Positive [18F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient by Veldhuijzen van Zanten, Sophie E. M., Neggers, Sebastian J. C. M. M., Valkema, Roelf, Verburg, Frederik A.

Get full text

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2 by van der Zijden, Charlène J, Lagarde, Sjoerd M, Hermus, Merel, Kranenburg, Leonieke W, van Lanschot, J Jan B, Mostert, Bianca, Nuyttens, Joost J M E, Oudijk, Lindsey, van der Sluis, Pieter C, Spaander, Manon C W, Valkema, Maria J, Valkema, Roelf, Wijnhoven, Bas P L

“…Neoadjuvant chemoradiotherapy (nCRT) followed by esophagectomy is a standard treatment for potentially curable esophageal cancer. Active surveillance in…”
Get full text

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study by Zhang, Xiaobin, Eyck, Ben M, Yang, Yang, Liu, Jun, Chao, Yin-Kai, Hou, Ming-Mo, Hung, Tsung-Min, Pang, Qingsong, Yu, Zhen-Tao, Jiang, Hongjing, Law, Simon, Wong, Ian, Lam, Ka-On, van der Wilk, Berend J, van der Gaast, Ate, Spaander, Manon C W, Valkema, Roelf, Lagarde, Sjoerd M, Wijnhoven, Bas P L, van Lanschot, J Jan B, Li, Zhigang

“…After neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer, high pathologically complete response (pCR) rates are being achieved especially in patients…”
Get full text

Reduction of renal uptake of radiolabeled octreotate by amifostine coadministration by Melis, Marleen, Valkema, Roelf, Krenning, Eric P, de Jong, Marion

“…Megalin-mediated renal retention of radiolabeled somatostatin analogs may lead to nephrotoxicity during peptide receptor radionuclide therapy (PRRT). The…”
Get full text

Peptide receptor radionuclide therapy by Forrer, Flavio, MD, Valkema, Roelf, MD, PhD, Kwekkeboom, Dik J., MD, PhD, de Jong, Marion, PhD, Krenning, Eric P., MD, PhD

“…Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues is an emerging and convincing treatment modality for patients with…”
Get full text

Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy by Pool, Stefan E., MD, Krenning, Eric P., MD, PhD, Koning, Gerben A., PhD, van Eijck, Casper H.J., MD, PhD, Teunissen, Jaap J.M., MD, PhD, Kam, Boen, MD, Valkema, Roelf, MD, PhD, Kwekkeboom, Dik J., MD, PhD, de Jong, Marion, PhD

“…In the 1980s, the111 In-labeled somatostatin analog OctreoScan (Covidien, Hazelwood, MO) was developed for imaging of somatostatin receptor subtype 2 (sst2 )…”
Get full text

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine by ROLLEMAN, Edgar J, VALKEMA, Roelf, DE JONG, Marion, KOOIJ, Péter P. M, KRENNING, Eric P

“…As scintigraphy with [(111)In-DTPA(0)]octreotide has become a standard technique in analysing somatostatin receptor-receptor positive lesions such as…”
Get full text

Eight-Year Prognostic Value of QRS Duration in Patients With Known or Suspected Coronary Artery Disease Referred for Myocardial Perfusion Imaging by Huurman, Roy, BSc, Boiten, Hendrik J., MD, Valkema, Roelf, MD, PhD, van Domburg, Ron T., PhD, Schinkel, Arend F.L., MD, PhD

“…QRS duration is of prognostic relevance in patients with several underlying heart diseases. Short-term data also show the prognostic value of QRS duration in…”
Get full text

Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings by de Jong, Marion, Valkema, Roelf, Jamar, Francois, Kvols, Larry K., Kwekkeboom, Dik J., Breeman, Wout A.P., Bakker, Willem H., Smith, Chuck, Pauwels, Stanislas, Krenning, Eric P.

“…In preclinical studies in rats we evaluated biodistribution and therapeutic effects of different somatostatin analogs, [ 111In-DTPA]octreotide, [ 90Y-DOTA, Tyr…”
Get full text

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives by Breeman, W A, de Jong, M, Kwekkeboom, D J, Valkema, R, Bakker, W H, Kooij, P P, Visser, T J, Krenning, E P

“…In vivo somatostatin receptor-mediated scintigraphy has proven to be a valuable method for the visualisation of neuroendocrine tumours and their metastases. A…”
Get full text

Dynamic and static small-animal SPECT in rats for monitoring renal function after 177Lu-labeled Tyr3-octreotate radionuclide therapy by Melis, Marleen, de Swart, Jan, de Visser, Monique, Berndsen, Saskia C, Koelewijn, Stuart, Valkema, Roelf, Boerman, Otto C, Krenning, Eric P, de Jong, Marion

“…High kidney radiation doses during clinical peptide receptor radionuclide therapy (PRRT) with β-particle-emitting radiolabeled somatostatin analogs will lead…”
Get full text

Treatment of Patients Who Have Endocrine Gastroenteropancreatic Tumors with Radiolabeled Somatostatin Analogues by Kwekkeboom, Dik J., MD, PhD, Teunissen, Jaap J.M., MD, Kam, Boen L., MD, Valkema, Roelf, MD, PhD, de Herder, Wouter W., MD, PhD, Krenning, Eric P., MD, PhD

“…Treatment with radiolabeled somatostatin analogs is a promising new tool in the management of patients who have inoperable or metastasized endocrine tumors…”
Get full text

Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events by Schinkel, Arend F.L., Elhendy, Abdou, van Domburg, Ron T., Bax, Jeroen J., Vourvouri, Eleni C., Bountioukos, Manos, Rizzello, Vittoria, Agricola, Eustachio, Valkema, Roelf, Roelandt, Jos R.T.C., Poldermans, Don

“…Technetium-99m (Tc-99m) tetrofosmin single-photon emission computed tomography (SPECT) is a useful alternative to thallium-201 scintigraphy for the assessment…”
Get full text

Accuracy of stress Tc-99m tetrofosmin myocardial perfusion tomography for the diagnosis and localization of coronary artery disease in women by Elhendy, Abdou, Schinkel, Arend F.L., Bax, Jeroen J., van Domburg, Ron T., Valkema, Roelf, Biagini, Elena, Feringa, Harm H., Poldermans, Don

“…Earlier studies have suggested a modest accuracy of stress thallium 201 myocardial perfusion imaging (MPI) for the diagnosis of coronary artery disease (CAD)…”
Get full text

Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: Impact of scintigraphic extent of coronary artery disease by Elhendy, Abdou, Schinkel, Arend F.L., van Domburg, Ron T., Bax, Jeroen J., Valkema, Roelf, Poldermans, Don

“…Our objective was to assess the prognostic value of the scintigraphic extent of coronary artery disease on stress technetium 99m tetrofosmin single photon…”
Get full text

Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes by SCHINKEL, Arend F. L, ELHENDY, Abdou, VAN DOMBURG, Ron T, BAX, Jeroen J, VOURVOURI, Eleni C, SOZZI, Fabiola B, VALKEMA, Roelf, ROELANDT, Jos R. T. C, POLDERNIANS, Don

“…Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes Arend F.L. Schinkel , MD , Abdou Elhendy , MD , Ron T…”
Get full text